and/or

12 Faculty Members found

Omar Abdel-Wahab, MD

Human Oncology & Pathogenesis Program

Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.

The Omar Abdel-Wahab Lab

Ping Chi, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic factors in GIST, MPNST, melanoma and other solid tumors.

Chi Lab

Yael David, PhD

Chemical Biology Program

Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.

The Yael David Lab

Lydia Finley, PhD

Cell Biology Program

Lydia Finley studies the mechanisms that link metabolic pathways to cell fate decisions.

The Lydia Finley Lab

Karuna Ganesh, MD, PhD

Molecular Pharmacology Program

Physician-scientist Karuna Ganesh studies stem cell plasticity in metastasis, therapy resistance and tissue regeneration.

Kristian Helin, PhD

Cell Biology Program

Cancer biologist Kristian Helin studies how genetic and epigenetic mechanisms affect transcription and cell-fate decisions, and how their deregulation contributes to cancer.

Helin Lab Group

Andrew M. Intlekofer, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Andrew Intlekofer investigates why cancer cells depend on specific pathways of nutrient metabolism.

Andrew Intlekofer Lab Group

Kitai Kim, PhD

Cancer Biology & Genetics Program

Stem cell biologist Kitai Kim studies epigenetic regulation of DNA methylation in stem cells and cancer.

The Kitai Kim Lab

Ross L. Levine, MD

Human Oncology & Pathogenesis Program

  1. Mechanisms of genetic and epigenetic cooperativity  which drive myeloid transformation
  2. Elucidating and modeling evolution from hematopoietic stem/progenitor cells to clonal hematopoiesis and then to myeloid malignancies
  3. Identification and credentialing novel therapeutic dependencies in myeloid malignancies

The Levine Lab

Minkui Luo, PhD

Chemical Biology Program

Chemical Biologist Minkui Luo develops cutting-edge tools, technologies and concepts to annotate functions of protein-posttranslational modifications and designs inhibitors for cancer therapies.

The Minkui Luo Lab